Colon Cancer Liver Metastasis Clinical Trial
Official title:
Factors Influencing the Impact of Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases
Contrast-enhanced intraoperative ultrasound (CE-IOUS) during surgery for colorectal liver metastases (CLM) has become a part of clinical practice. However, if it should be selectively or routinely applied remains unclear. This study is carried out to clarify which are the criteria for a selective use of CE-IOUS if any.
Contrast-enhanced intraoperative ultrasound (CE-IOUS) during surgery for colorectal liver metastases (CLM) is entered in clinical practice. However, its impact seems to decrease with the improvement of preoperative imaging. Therefore, if CE-IOUS should be selectively or routinely applied remains unclear: a profile of patients who may benefit of CE-IOUS application has to be disclosed. The aim of this study is to define reliable criteria for a selective use of CE-IOUS during surgery for CLM. IOUS is performed using 3-6 MHz convex probe, and a 7.5-10 MHz micro convex probe. Staging is completed by CE-IOUS using the standard 3-6 MHz convex probe and the dedicated 1.88-3.76 MHz harmonic frequency probe. In all patients, 2.4 mL of sulphur-hexafluoride microbubbles (SonoVue®, Bracco, Milan, Italy) are injected through a peripheral vein by the anesthesiologist. Ultrasound guidance is used to drive the dissection plane as previously described. Reference standards are histology and imaging at 6 months after surgery. Univariate and multivariate analyses are performed. Statistical significance is set at P=0.05. ;
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01540435 -
Perioperative Treatment of Resectable Liver Metastases
|
Phase 2 | |
| Terminated |
NCT01464593 -
Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
|
Phase 2 | |
| Completed |
NCT02090816 -
Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy
|
N/A | |
| Recruiting |
NCT04682665 -
Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases
|
||
| Completed |
NCT01730365 -
Optical Detection of Malignancy During Percutaneous Interventions
|
N/A | |
| Terminated |
NCT03370198 -
Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT02781935 -
Diffusion-Weighted MRI for Liver Metastasis
|
||
| Completed |
NCT01891552 -
Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab
|
N/A | |
| Recruiting |
NCT05293041 -
Argipressin's Influence on Blood Loss During Hepatic Resection
|
Phase 4 | |
| Recruiting |
NCT02631564 -
Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis
|
N/A | |
| Recruiting |
NCT03175016 -
Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer
|
Phase 2/Phase 3 | |
| Recruiting |
NCT02363049 -
Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer
|
Phase 3 | |
| Recruiting |
NCT02557490 -
Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases
|
Phase 4 | |
| Completed |
NCT03415126 -
A Study of ASN007 in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT04668872 -
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
|
||
| Completed |
NCT01522209 -
Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging
|
N/A | |
| Active, not recruiting |
NCT03310008 -
Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases
|
Phase 1 |